$PPCB
Propanc Biopharma Inc

2016 Q1 Form 10-Q Financial Statement

#000114420416082302 Filed on February 16, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2014 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $780.0K $1.000M $250.0K
YoY Change 52.94% 300.0% 8.7%
% of Gross Profit
Research & Development $510.3K $142.8K $2.443K
YoY Change 5285.76% 5745.4%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.291M $1.144M $249.4K
YoY Change 149.87% 358.55% 10.64%
Operating Profit -$1.144M -$249.4K
YoY Change 358.55% 10.64%
Interest Expense $1.104M $1.156M $100.2K
YoY Change 454.13% 1053.61% 395.31%
% of Operating Profit
Other Income/Expense, Net -$861.1K -$2.490M -$178.5K
YoY Change -1481.89% 1295.27% -187.75%
Pretax Income -$2.152M -$3.630M -$427.9K
YoY Change 373.72% 748.29% 1840.5%
Income Tax $0.00 -$72.00K -$82.44K
% Of Pretax Income
Net Earnings -$2.150M -$3.562M -$345.5K
YoY Change 373.31% 931.05% -1408.68%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$526.6M -$1.114B $415.3M
COMMON SHARES
Basic Shares Outstanding 475.6M shares 397.1M shares 90.96M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.480M $1.170M $10.00K
YoY Change 770.59% 11600.0%
Cash & Equivalents $14.59K
Short-Term Investments
Other Short-Term Assets $120.0K $330.0K $40.00K
YoY Change -7.69% 725.0% 300.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.618M $1.500M $52.94K
YoY Change 423.86% 2733.4% 429.4%
LONG-TERM ASSETS
Property, Plant & Equipment $3.678K $3.671K
YoY Change 355.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $5.365K $10.00K $0.00
YoY Change 563.99%
TOTAL ASSETS
Total Short-Term Assets $1.618M $1.500M $52.94K
Total Long-Term Assets $5.365K $10.00K $0.00
Total Assets $1.623M $1.510M $52.94K
YoY Change 424.22% 2752.29% 429.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $159.3K $110.0K $88.09K
YoY Change -45.26% 24.87% -71.58%
Accrued Expenses $150.0K $120.0K $280.0K
YoY Change -65.91% -57.14% -24.32%
Deferred Revenue
YoY Change
Short-Term Debt $1.060M $2.010M $951.4K
YoY Change -15.2% 111.26% 494.64%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.144M $4.864M $1.930M
YoY Change 138.08% 151.99% 82.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.144M $4.864M $1.930M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $5.140M $4.860M $1.930M
YoY Change 137.96% 151.81% 82.08%
SHAREHOLDERS EQUITY
Retained Earnings -$27.52M -$25.37M $18.68M
YoY Change 43.78% -235.78%
Common Stock $602.5K $432.7K $130.8K
YoY Change 81.04% 230.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.520M -$3.356M -$1.877M
YoY Change
Total Liabilities & Shareholders Equity $1.620M $1.508M $52.94K
YoY Change 423.22% 2748.49% 429.4%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2014 Q4
OPERATING ACTIVITIES
Net Income -$2.150M -$3.562M -$345.5K
YoY Change 373.31% 931.05% -1408.68%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$720.0K -$1.080M -$170.0K
YoY Change 67.44% 535.29% 750.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.200M 2.050M 80.00K
YoY Change 106.9% 2462.5% -500.0%
NET CHANGE
Cash From Operating Activities -720.0K -1.080M -170.0K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 1.200M 2.050M 80.00K
Net Change In Cash 480.0K 970.0K -90.00K
YoY Change 220.0% -1177.78% 125.0%
FREE CASH FLOW
Cash From Operating Activities -$720.0K -$1.080M -$170.0K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$720.0K -$1.080M -$170.0K
YoY Change 67.44% 535.29% 750.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71421 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21360201 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20965671 USD
CY2015Q4 us-gaap Security Deposit
SecurityDeposit
1606 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2189 USD
CY2015Q2 us-gaap Notes Payable Current
NotesPayableCurrent
27558 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1845108 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
475913 USD
us-gaap Occupancy Costs
OccupancyCosts
9827 USD
us-gaap Occupancy Costs
OccupancyCosts
5344 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
296277 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6322 USD
us-gaap Operating Expenses
OperatingExpenses
2151212 USD
us-gaap Operating Expenses
OperatingExpenses
487579 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2151212 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-487579 USD
us-gaap Interest Expense
InterestExpense
1574289 USD
us-gaap Interest Expense
InterestExpense
648655 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2027 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
3 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
50002 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-138704 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-182612 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2321749 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-723640 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4472961 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1211219 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-72000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-82440 USD
us-gaap Net Income Loss
NetIncomeLoss
-4400961 USD
us-gaap Net Income Loss
NetIncomeLoss
-1128779 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
111879 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
218137 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
34884 USD
us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
CY2015Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
996129 USD
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244431 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4863852 USD
CY2015Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1794375 USD
CY2015Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2511405 USD
CY2015Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
780281 USD
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
82086 USD
CY2015Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
269648 USD
CY2015Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
33471 USD
CY2015Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
35108 USD
CY2015Q4 ppch Loans From Related Party
LoansFromRelatedParty
54005 USD
CY2015Q2 ppch Loans From Related Party
LoansFromRelatedParty
79416 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
80538 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3680584 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
432720 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
347442 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43505 USD
CY2015Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
386311 USD
CY2015Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1949519 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17458745 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
212847 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
100968 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25366632 USD
CY2015Q2 us-gaap Security Deposit
SecurityDeposit
1684 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-551890 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
122742 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4289082 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-910642 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
375025485 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
85827403 shares
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-58893 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-3355864 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-3053516 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1507988 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
627068 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3671 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3494 USD
ppch Discounts Related To Lender Costs
DiscountsRelatedToLenderCosts
0 USD
ppch Discounts Related To Lender Costs
DiscountsRelatedToLenderCosts
33500 USD
CY2015Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1347743 USD
CY2014Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
8206 USD
CY2015Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3708618 USD
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-242159 USD
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2015Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
399822354 shares
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
95007061 shares
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1122322 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
112268 USD
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-72000 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-82440 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-676 USD
us-gaap Interest Paid
InterestPaid
0 USD
ppch Discounts Related To Derivative Liability
DiscountsRelatedToDerivativeLiability
0 USD
CY2015Q4 us-gaap Occupancy Costs
OccupancyCosts
4889 USD
CY2014Q4 us-gaap Occupancy Costs
OccupancyCosts
2567 USD
CY2015Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
142803 USD
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2443 USD
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
1143821 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
249441 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1143821 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-249441 USD
CY2015Q4 us-gaap Interest Expense
InterestExpense
1155645 USD
CY2014Q4 us-gaap Interest Expense
InterestExpense
100176 USD
CY2015Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2014Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2015Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2014Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2015Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
72035 USD
CY2014Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-157655 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-3562067 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-345479 USD
CY2015Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-146551 USD
CY2014Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
103320 USD
CY2015Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-58893 USD
CY2014Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
71147 USD
CY2014Q4 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
CY2015Q4 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
us-gaap Depreciation
Depreciation
340 USD
us-gaap Depreciation
Depreciation
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1224235 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
117231 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-755927 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-165428 USD
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
343259 USD
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-118305 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
46849 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12447 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3915 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-324789 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
46585 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1488222 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-271996 USD
us-gaap Payments For Loans
PaymentsForLoans
21500 USD
us-gaap Payments For Loans
PaymentsForLoans
20000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2977500 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
90000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2468172 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
99000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
81217 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
99785 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
1060491 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-73211 USD
CY2014Q2 us-gaap Cash
Cash
87799 USD
CY2014Q4 us-gaap Cash
Cash
14588 USD
us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q2 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.55 pure
CY2015Q4 us-gaap Share Price
SharePrice
0.0279
CY2015Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1049929 USD
ppch Reimbursement On Goods And Service Tax Receivable Percentage
ReimbursementOnGoodsAndServiceTaxReceivablePercentage
1 pure
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
PPCH
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
475610250 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2015Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
2511405 USD
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
82086 USD
CY2015Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2593491 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
ppch Conversion Of Convertible Notes And Accrued Interest To Common Stock
ConversionOfConvertibleNotesAndAccruedInterestToCommonStock
1762430 USD
ppch Conversion Of Convertible Notes And Accrued Interest To Common Stock
ConversionOfConvertibleNotesAndAccruedInterestToCommonStock
177567 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-10005 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7308 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
676 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
ppch Prepaid Common Stock Issued For Services
PrepaidCommonStockIssuedForServices
187532 USD
ppch Prepaid Common Stock Issued For Services
PrepaidCommonStockIssuedForServices
134373 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
636348 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
37032 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
20509 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
-58893 USD
us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
-355000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1226 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4296 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
463976 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
ppch Conversion Of Loan Payable To Common Stock
ConversionOfLoanPayableToCommonStock
0 USD
ppch Conversion Of Loan Payable To Common Stock
ConversionOfLoanPayableToCommonStock
66389 USD
ppch Discounts Related To Derivative Liability
DiscountsRelatedToDerivativeLiability
1005925 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
23852 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 USD
CY2015Q4 ppch Working Capital Deficit
WorkingCapitalDeficit
3361141 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
21500 USD
CY2015Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
782500 USD
ppch Fair Value Of Warrant Derivative Liability Recoreded As Change In Fair Value Of Eco
FairValueOfWarrantDerivativeLiabilityRecorededAsChangeInFairValueOfEco
1369261 USD
us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
14253 USD
ppch Fair Value Of Warrant Derivative Liability Recoreded As Debt Discount
FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount
1005925 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-817371 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5344 USD
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
500000 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
33569634 shares
CY2015Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
352500 USD
CY2015Q2 ppch Debt Convertible Note Cash Purchase
DebtConvertibleNoteCashPurchase
220000 USD
CY2015Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
20000 USD
CY2015Q2 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
1997 USD
CY2015Q2 ppch Net Proceeds From Notes Issued
NetProceedsFromNotesIssued
201997 USD
CY2015Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.07
CY2015Q3 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
17690 USD
CY2015Q3 ppch Percentage Of Lowest Trading Bid Price
PercentageOfLowestTradingBidPrice
0.55 pure
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
dei Entity Registrant Name
EntityRegistrantName
Propanc Health Group Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001517681
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
432719886 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
432719886 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
347442013 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
347442013 shares
ppch Issuance Of Preferred Stock For Services
IssuanceOfPreferredStockForServices
0 USD
ppch Issuance Of Preferred Stock For Services
IssuanceOfPreferredStockForServices
1067 USD
ppch Settlement Fees Paid In Form Of Debt
SettlementFeesPaidInFormOfDebt
0 USD
ppch Settlement Fees Paid In Form Of Debt
SettlementFeesPaidInFormOfDebt
125000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-100 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29000 USD
ppch Discounts Related To Warrants Issued With Convertible Debenture
DiscountsRelatedToWarrantsIssuedWithConvertibleDebenture
1619075 USD
ppch Discounts Related To Warrants Issued With Convertible Debenture
DiscountsRelatedToWarrantsIssuedWithConvertibleDebenture
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><u><font style="COLOR: black; FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Actual results could differ from these estimates.&#160;Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
29744 AUD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
33000 AUD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-744 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 USD
CY2015Q4 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
26190476 USD
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.60
CY2015Q4 ppch Warrants Expire Period
WarrantsExpirePeriod
P4Y
ppch Promissory Note Payable Issued For Services
PromissoryNotePayableIssuedForServices
50000 USD
CY2015Q4 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
407735 USD
CY2015Q4 ppch Percentage Of Conversion Rate Of Lowest Trading Bid Price
PercentageOfConversionRateOfLowestTradingBidPrice
0.55 pure
CY2015Q4 ppch Accreted Put Premium
AccretedPutPremium
351818 USD
ppch Accreted Put Premium
AccretedPutPremium
179818 USD
CY2015Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7339 USD
ppch Debt Discounts For Fees Paid
DebtDiscountsForFeesPaid
2887500 USD
ppch Debt Discounts For Fees Paid
DebtDiscountsForFeesPaid
63500 USD
CY2015Q4 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
430000 USD
CY2015Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
22265 USD
CY2014Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
25000 USD
CY2015Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
782500 USD
CY2014Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
250000 USD
CY2015Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1500000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
400000 shares
CY2015 ppch Reimbursement On Goods And Service Tax Receivable Percentage
ReimbursementOnGoodsAndServiceTaxReceivablePercentage
1 pure

Files In Submission

Name View Source Status
0001144204-16-082302-index-headers.html Edgar Link pending
0001144204-16-082302-index.html Edgar Link pending
0001144204-16-082302.txt Edgar Link pending
0001144204-16-082302-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ppch-20151231.xml Edgar Link completed
ppch-20151231.xsd Edgar Link pending
ppch-20151231_cal.xml Edgar Link unprocessable
ppch-20151231_def.xml Edgar Link unprocessable
ppch-20151231_lab.xml Edgar Link unprocessable
ppch-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v431178_10q.htm Edgar Link pending
v431178_ex31-1.htm Edgar Link pending
v431178_ex32-1.htm Edgar Link pending